Huang Guang-Qing, Ke Zun-Ping, Hu Hai-Bo, Gu Biao
a Department of Intensive Care Unit , Renmin Hospital, Hubei University of Medicine , Shiyan , Hubei , P.R. China.
b Department of Cardiology , The Fifth People's Hospital of Shanghai, Fudan University , Shanghai , China.
Cancer Biol Ther. 2017 Feb;18(2):115-122. doi: 10.1080/15384047.2017.1281494.
Lung squamous cell carcinoma(LSCC) is the most common and aggressive lung tumor with poor clinical outcome. Previously studies showed that deregulation of long noncoding RNAs (lncRNAs) were involved in LSCC. We intended to figure out the role of lncRNAs in the regulation process of cancer-related genes and pathways they are involved. Data of 552 samples, including 501 cancer samples and 51 normal ones, were extracted from The Cancer Genome Atlas (TCGA). Differentially expressed lncRNAs (DEIs) were screened out (FDR<0.05, |logFC|>1) and then followed by GO ontology and KEGG annotation analysis. Oncogenes from COSMIC data set and Tumor suppressor genes (TSGs) from TSGene data set were collected and analyzed by gene Set Enrichment Analysis (GSEA) . The differentially expressed oncogenes and tumor supressor gene (TSGs) were obtained and co-expression analysis was conducted to generate co-expression lncRNA-gene pairs, which can be helpful in figuring out the role of lncRNA in the regulation of oncogenes and tumor suppressor genes. A total of 31 lncRNAs with low expression levels and 37 lncRNAs with high expression levels were screened out and most of them were enriched in pathways such as meiosis, male gamete generation, defensins. Of note, SFTA1P and CASC2 were found to be related with most of the oncogenes and TSGs by co-expression analysis. We suggested SFTA1P and CASC2 played important role in the regulation of both oncogene and TSGs during the carcinogenesis of LSCC and have the potential to be applied in future diagnosis, prognostic process and target therapy of LSCC.
肺鳞状细胞癌(LSCC)是最常见且侵袭性最强的肺部肿瘤,临床预后较差。先前的研究表明,长链非编码RNA(lncRNAs)失调与LSCC有关。我们旨在弄清楚lncRNAs在癌症相关基因的调控过程及其所涉及的通路中的作用。从癌症基因组图谱(TCGA)中提取了552个样本的数据,包括501个癌症样本和51个正常样本。筛选出差异表达的lncRNAs(FDR<0.05,|logFC|>1),然后进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)注释分析。收集来自癌症体细胞突变目录(COSMIC)数据集的癌基因和来自肿瘤抑制基因(TSG)数据集的肿瘤抑制基因,并通过基因集富集分析(GSEA)进行分析。获得差异表达的癌基因和肿瘤抑制基因,并进行共表达分析以生成共表达的lncRNA-基因对,这有助于弄清楚lncRNA在癌基因和肿瘤抑制基因调控中的作用。共筛选出31个低表达水平的lncRNAs和37个高表达水平的lncRNAs,其中大多数富集于减数分裂、雄配子生成、防御素等通路。值得注意的是,通过共表达分析发现鳞状细胞癌相关抗原1假基因(SFTA1P)和癌症易感候选基因2(CASC2)与大多数癌基因和肿瘤抑制基因相关。我们认为SFTA1P和CASC2在LSCC致癌过程中对癌基因和肿瘤抑制基因的调控中起重要作用,并且有潜力应用于未来LSCC的诊断、预后评估和靶向治疗。